Editor’s Note: This article is a reprint. It was originally published September 28, 2018. When it comes to cozy business relationships between government and industry, there is nothing like the lucrative one that Congress has encouraged federal health agencies to create with the drug and vaccine industry. One hand washes the other. Have you ever… Read More »
Aluminum, the most commonly used vaccine adjuvant,1 may be increasing the risk of asthma in children when injected as part of the standard childhood vaccine schedule. The finding comes from a study funded by the U.S. Centers for Disease Control and Prevention (CDC), raising concerns about the cumulative aluminum exposure children receive when they get… Read More »
Millions of people who received the Pfizer COVID-19 vaccine have been eligible to get a third booster dose for weeks, but those who received the other FDA-authorized shots have been waiting to see whether they’ll need another dose. They’ll soon have answers. FDA vaccine advisors are set to meet Thursday and Friday to discuss the prospect of giving… Read More »
The Coronavirus Pandemic Covid-19 Updates Coronavirus Map and Cases Vaccine FAQ World Vaccination Tracker Advertisement Continue reading the main story Supported by Continue reading the main story A New Vaccine Strategy for Children: Just One Dose, for Now Myocarditis, a rare side effect, occurs mostly after the second dose. So in some countries, officials are trying… Read More »
Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to research from the Stanford University School of Medicine. The findings will be published online Sept. 17 in JAMA Network Open. “We wanted to understand the spectrum of allergies to the… Read More »